Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor in lung cancer

Mutant selective epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs), such as rociletinib and AZD9291, are effective for tumors with T790M secondary mutation that become refractory to first‐generation EGFR‐TKI. However, acquired resistance to these prospective drugs is anticipate...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Sci
Main Authors: Mizuuchi, Hiroshi, Suda, Kenichi, Murakami, Isao, Sakai, Kazuko, Sato, Katsuaki, Kobayashi, Yoshihisa, Shimoji, Masaki, Chiba, Masato, Sesumi, Yuichi, Tomizawa, Kenji, Takemoto, Toshiki, Sekido, Yoshitaka, Nishio, Kazuto, Mitsudomi, Tetsuya
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2016
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4832847/
https://ncbi.nlm.nih.gov/pubmed/26845230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12905
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍